Recombinante

· Bio-Manguinhos / Oswaldo Cruz Foundation (Fiocruz)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Recombinante, covering 2021-12-02 to 2021-12-02. Get the full timeline:

Most recent: Clinical Trial Update: Study of Immunogenicity Equivalence of a Homologous Third Dose of Covid-19 (Recombinante) Vaccine [Phase 4]